Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Lam

Patient-Derived First Generation Xenografts of Non-Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy

Clinical Cancer Research

Cancer Research

Oncology

2010

English

Identification of Airway Mucosal Type 2 Inflammation by Using Clinical Biomarkers in Asthmatic Patients

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2017

English

MA 05.12 Oncogenic Drivers Induce Production of CCL5 to Recruit Regulatory T-Cells Early in Lung Cancer Progression

Journal of Thoracic Oncology

English

P1.11-10 Optimizing Radiomics Features by Minimizing Boundary Effects and Normalizing With Opposite Lung Tissue Characteristics

Journal of Thoracic Oncology

English

MA03.02 Prospective Evaluation of the Clinical Utility of the International Lung Screen Trial Lung Nodule Management Protocol

Journal of Thoracic Oncology

English

P1.16-34 the Impact of Pathology, Staging and Operative Resection on Survival and CT Evidence of Recurrence of Early NSCLC

Journal of Thoracic Oncology

English

P2.11-23 Risk Perception Among a Lung Cancer Screening Population

Journal of Thoracic Oncology

English

PL02.07 IMpower 133: Primary PFS, OS and Safety in a PH1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in Extensive-Stage SCLC

Journal of Thoracic Oncology

English

P3.09-11 Genomic Organization at Large Scales (GOALS) Within Nuclei and Cell Sociology for Predicting Lung Cancer Outcomes

Journal of Thoracic Oncology

English

P3.11-03 Implementing Lung Cancer Screening in Canada: Evidence on Adherence and Budget Impact From the Pan-Canadian Early Detection Study

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Lam

Patient-Derived First Generation Xenografts of Non-Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy

Identification of Airway Mucosal Type 2 Inflammation by Using Clinical Biomarkers in Asthmatic Patients

MA 05.12 Oncogenic Drivers Induce Production of CCL5 to Recruit Regulatory T-Cells Early in Lung Cancer Progression

P1.11-10 Optimizing Radiomics Features by Minimizing Boundary Effects and Normalizing With Opposite Lung Tissue Characteristics

MA03.02 Prospective Evaluation of the Clinical Utility of the International Lung Screen Trial Lung Nodule Management Protocol

P1.16-34 the Impact of Pathology, Staging and Operative Resection on Survival and CT Evidence of Recurrence of Early NSCLC

P2.11-23 Risk Perception Among a Lung Cancer Screening Population

PL02.07 IMpower 133: Primary PFS, OS and Safety in a PH1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in Extensive-Stage SCLC

P3.09-11 Genomic Organization at Large Scales (GOALS) Within Nuclei and Cell Sociology for Predicting Lung Cancer Outcomes

P3.11-03 Implementing Lung Cancer Screening in Canada: Evidence on Adherence and Budget Impact From the Pan-Canadian Early Detection Study